ENTRY       D03693                      Drug
NAME        Desloratadine (JAN/USP/INN);
            Clarinex (TN)
PRODUCT     CLARINEX (Organon LLC)
  GENERIC   DESLORATADINE (A-S Medication Solutions)
            DESLORATADINE (A-S Medication Solutions)
            DESLORATADINE (A-S Medication Solutions)
            DESLORATADINE (AvKARE)
            DESLORATADINE (Belcher Pharmaceuticals)
            DESLORATADINE (Bryant Ranch Prepack)
            DESLORATADINE (Dr. Reddy's Laboratories Limited)
            DESLORATADINE (Lupin Pharmaceuticals)
            DESLORATADINE (Virtus Pharmaceuticals)
FORMULA     C19H19ClN2
EXACT_MASS  310.1237
MOL_WEIGHT  310.8206
CLASS       Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
            Dermatological agent
             DG03243  Atopic dermatitis agent
REMARK      Therapeutic category: 4490
            ATC code: R06AX27
            Product: D03693<JP/US>
            Product (mixture): D10850<US>
EFFICACY    Antiallergic, Antipruritic, H1 receptor antagonist
  DISEASE   Allergic rhinitis [DS:H01360]
COMMENT     Treatment of seasonal allergic rhinitis
TARGET      HRH1 [HSA:3269] [KO:K04149]
  PATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction
            hsa04750(3269)  Inflammatory mediator regulation of TRP channels
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R06 ANTIHISTAMINES FOR SYSTEMIC USE
               R06A ANTIHISTAMINES FOR SYSTEMIC USE
                R06AX Other antihistamines for systemic use
                 R06AX27 Desloratadine
                  D03693  Desloratadine (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Antihistamines
               Histamine (H1) Receptor Antagonists, Mildly/Non-sedating
                Desloratadine
                 D03693  Desloratadine (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              44  Allergic agents
               449  Miscellaneous
                4490  Miscellaneous
                 D03693  Desloratadine (JAN/USP/INN)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                D03693  Desloratadine
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D03693  Desloratadine
            Drug classes [BR:br08332]
             Anti-allergic agent
              DG01482  Histamine receptor H1 antagonist
               D03693  Desloratadine
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D03693  Desloratadine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D03693  Desloratadine (JAN/USP/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03693
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03693
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03693
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03693
DBLINKS     CAS: 100643-71-8
            PubChem: 17397787
            ChEBI: 291342
            LigandBox: D03693
ATOM        22
            1   C1x C    15.9600  -18.2700
            2   C8y C    15.1200  -17.1500
            3   C8y C    15.4000  -15.7500
            4   C2y C    16.7300  -15.1900
            5   C1x C    17.3600  -18.2700
            6   C8y C    17.9200  -15.8200
            7   C8y C    18.2700  -17.2200
            8   C8x C    14.4200  -14.8400
            9   C8x C    13.0900  -15.1900
            10  C8y C    12.7400  -16.5900
            11  C8x C    13.7200  -17.5000
            12  C8x C    19.6000  -17.6400
            13  C8x C    20.6500  -16.7300
            14  C8x C    20.3700  -15.3300
            15  N5x N    18.9700  -14.9100
            16  C2y C    16.7300  -13.7900
            17  X   Cl   11.3979  -16.9886
            18  C1x C    17.9424  -13.0900
            19  C1x C    17.9424  -11.6900
            20  N1x N    16.7300  -10.9900
            21  C1x C    15.5176  -11.6900
            22  C1x C    15.5176  -13.0900
BOND        25
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    6  15 2
            18    4  16 2
            19   10  17 1
            20   16  18 1
            21   18  19 1
            22   19  20 1
            23   20  21 1
            24   21  22 1
            25   16  22 1
///
